Skip to main content

Peer Review reports

From: Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose

Original Submission
11 Nov 2022 Submitted Original manuscript
14 Dec 2022 Reviewed Reviewer Report - Yee-min Jen
28 Feb 2023 Reviewed Reviewer Report - Daniel Chua
10 Mar 2023 Author responded Author comments - Xing Lv
22 Mar 2023 Reviewed Reviewer Report - Daniel Chua
1 Apr 2023 Author responded Author comments - Xing Lv
Resubmission - Version 2
10 Mar 2023 Submitted Manuscript version 2
Publishing
7 Apr 2023 Editorially accepted
6 May 2023 Article published 10.1186/s12885-023-10827-0

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us